Guggenheim Maintains Buy on Bruker, Raises Price Target to $72

Guggenheim analyst Subbu Nambi has maintained a 'Buy' rating on Bruker (NASDAQ: BRKR) and increased the price target from $70 to $72. This adjustment reflects a positive outlook on the company's performance.